PharmswellBio Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Public

  • Employees
  • 19

Employees

  • Stock Symbol
  • 043090

Stock Symbol

  • Share Price
  • $0.41
  • (As of Wednesday Closing)

PharmswellBio General Information

Description

Exergy21 Co Ltd is specializing in air conditioning and heating systems.

Contact Information

Website
www.exergy21.net
Formerly Known As
Ko Bio Tech Co
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • Star Valley, 99 Digital-ro 9-gil
  • Geumcheon-gu
  • Seoul, 08510
  • South Korea
+82 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmswellBio Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.41 $0.41 $0.39 - $2.18 $24M 59.1M 431K -$0.32

PharmswellBio Financials Summary

In Thousands,
USD 		TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 31,626 62,262 54,348 32,042
Revenue 8,491 3,016 7,725 4,410
EBITDA (14,143) (763) (1,261) (4,941)
Net Income (16,932) (2,586) (2,356) (5,700)
Total Assets 56,593 57,721 48,304 23,405
Total Debt 8,945 6,836 12,596 486
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PharmswellBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmswellBio‘s full profile, request access.

Request a free trial

PharmswellBio Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

PharmswellBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060286631-A1 Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene Inactive 01-Sep-2003 0000000000
US-7223590-B2 Via streptomyces carbophilus culture mutated via ultraviolet radiation Inactive 29-Sep-2001 00000000 0
US-20040259216-A1 Via streptomyces carbophilus culture mutated via ultraviolet radiation Active 29-Sep-2001 C12N1/20

PharmswellBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmswellBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PharmswellBio‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial